0015

Ahn-Gook Pharmaceutical Co., Ltd. (001540)

Market Open
16 May, 06:30
KRX SM KRX SM
7,140. 00
-10
-0.14%
81.15B Market Cap
- P/E Ratio
880% Div Yield
45,189 Volume
- Eps
7,150
Previous Close
Day Range
7,070 7,250
Year Range
6,230 8,600

Summary

001540 trading today lower at ₩7,140, a decrease of 0.14% from yesterday's close, completing a monthly increase of 0% or ₩0. Over the past 12 months, 001540 stock gained 9.34%.
001540 is not paying dividends to its shareholders.
Ahn-Gook Pharmaceutical Co., Ltd. has completed 1 stock splits, with the recent split occurring on Dec 29, 2014.
The company's stock is traded on 1 different exchanges and in various currencies, with the primary listing on KRX SM (KRW).
Want to track 001540 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

001540 Chart

Ahn-Gook Pharmaceutical Co., Ltd. (001540) FAQ

What is the stock price today?

The current price is ₩7,140.00.

On which exchange is it traded?

Ahn-Gook Pharmaceutical Co., Ltd. is listed on KRX SM.

What is its stock symbol?

The ticker symbol is 001540.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 81.15B.

Has Ahn-Gook Pharmaceutical Co., Ltd. ever had a stock split?

Ahn-Gook Pharmaceutical Co., Ltd. had 1 splits and the recent split was on Dec 29, 2014.

Ahn-Gook Pharmaceutical Co., Ltd. Profile

Drug Manufacturers - Specialty & Generic Industry
Healthcare Sector
- CEO
KRX SM Exchange
- ISIN
South Korea Country
400 Employees
- Last Dividend
29 Dec 2014 Last Split
- IPO Date

Overview

Ahn-Gook Pharmaceutical Co., Ltd. is an established player in the pharmaceutical industry, founded in 1959 and strategically headquartered in Seoul, South Korea. The company has carved out a niche in the manufacturing and marketing of pharmaceutical products, consolidating its presence both domestically and on the international stage. Its commitment to improving human health and its relentless pursuit of innovation and quality has positioned Ahn-Gook Pharmaceutical as a trusted brand among healthcare professionals and patients alike. With a history spanning over six decades, the company continues to lead with its forward-thinking approaches, adapting to the evolving healthcare landscape and expanding its product portfolio to meet the varied needs of the global market.

Products and Services

  • Cinatura: This is one of the flagship products of Ahn-Gook Pharmaceutical, known for its effectiveness in managing certain medical conditions. As a proprietary medicine, Cinatura represents the company’s commitment to research and development, showcasing their ability to create innovative solutions for health care challenges.
  • Revo Tension: Another prominent offering, Revo Tension, underscores Ahn-Gook Pharmaceutical's prowess in addressing cardiovascular diseases. Designed to help patients manage blood pressure, this medication is a testament to the company's dedication to contributing to the global fight against hypertension and related conditions.

In addition to these products, Ahn-Gook Pharmaceutical Co., Ltd. continually invests in the development of new pharmaceuticals and healthcare solutions. With a robust R&D infrastructure, the company is able to extend its product lines to include treatments for a variety of ailments, thereby enhancing patient care and improving quality of life on a global scale.

Contact Information

Address: 613 Siheung -daero
Phone: 82 2 3289 4226